NASDAQ:LFST - Nasdaq - US53228F1012 - Common Stock - Currency: USD
NASDAQ:LFST (5/6/2025, 9:32:40 AM)
6.55
-0.07 (-1.06%)
The current stock price of LFST is 6.55 USD. In the past month the price decreased by -0.3%. In the past year, price decreased by -3.5%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.1 | 90.58B | ||
CVS | CVS HEALTH CORP | 10.52 | 84.47B | ||
LH | LABCORP HOLDINGS INC | 16.64 | 20.51B | ||
DGX | QUEST DIAGNOSTICS INC | 19.2 | 19.70B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.71 | 15.88B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 120.37 | 13.07B | ||
DVA | DAVITA INC | 14.85 | 10.84B | ||
HIMS | HIMS & HERS HEALTH INC | 58.78 | 9.07B | ||
CHE | CHEMED CORP | 24.41 | 8.42B | ||
CRVL | CORVEL CORP | 26.23 | 5.63B | ||
OPCH | OPTION CARE HEALTH INC | 24.28 | 5.41B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Lifestance Health Group, Inc. provides outpatient mental health services. The company is headquartered in Scottsdale, Arizona and currently employs 10,218 full-time employees. The company went IPO on 2021-06-10. The firm is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The company treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. The company employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LIFESTANCE HEALTH GROUP INC
4800 N. Scottsdale Road, Suite 2500
Scottsdale ARIZONA US
CEO: Michael K. Lester
Employees: 6984
Phone: 16027672100
The current stock price of LFST is 6.55 USD. The price decreased by -1.06% in the last trading session.
The exchange symbol of LIFESTANCE HEALTH GROUP INC is LFST and it is listed on the Nasdaq exchange.
LFST stock is listed on the Nasdaq exchange.
15 analysts have analysed LFST and the average price target is 9.01 USD. This implies a price increase of 37.56% is expected in the next year compared to the current price of 6.55. Check the LIFESTANCE HEALTH GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LIFESTANCE HEALTH GROUP INC (LFST) has a market capitalization of 2.55B USD. This makes LFST a Mid Cap stock.
LIFESTANCE HEALTH GROUP INC (LFST) currently has 6984 employees.
LIFESTANCE HEALTH GROUP INC (LFST) has a support level at 6.6 and a resistance level at 6.81. Check the full technical report for a detailed analysis of LFST support and resistance levels.
The Revenue of LIFESTANCE HEALTH GROUP INC (LFST) is expected to grow by 14.41% in the next year. Check the estimates tab for more information on the LFST EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LFST does not pay a dividend.
LIFESTANCE HEALTH GROUP INC (LFST) will report earnings on 2025-05-07, before the market open.
LIFESTANCE HEALTH GROUP INC (LFST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.16).
The outstanding short interest for LIFESTANCE HEALTH GROUP INC (LFST) is 8.1% of its float. Check the ownership tab for more information on the LFST short interest.
ChartMill assigns a fundamental rating of 3 / 10 to LFST. The financial health of LFST is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months LFST reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 68.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.71% | ||
ROE | -3.97% | ||
Debt/Equity | 0.19 |
ChartMill assigns a Buy % Consensus number of 80% to LFST. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 40.23% and a revenue growth 14.41% for LFST